Zacks Investment Research

Based in California, Revolve Group (NYSE:RVLV) RVLV is a popular online fashion retailer, selling a wide range of men’s and women’s apparel, shoes, accessories, and beauty items; their...

Invo BioScience Inc. (INVO) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.27 per share a year ago. These figures...

(1:00) - The Future of The Metaverse: What Exactly Is It?(9:45) - Gaining Exposure To The Metaverse: Who Will Be The Leaders?(13:20) - Breaking Down The Ball (NYSE:BLL) Metaverse Index(20:45) - Why Is...

Earnings season is winding down but it’s not over yet. About 260 companies are expected to report earnings this week including many of the big cap retailers. Retail has been a popular reopen...

Managing your risk is a big part of investing. Because everyone would like themselves to err on the upside, i.e. you end up making more than you were targeting. But heaven forbid that you err on the...

Azul’s AZUL stock has declined 3.6% since its earnings release on Aug 12. The wider-than-expected loss posted by the company for second-quarter 2021 in the current scenario of improving...

Wall Street delivered a moderate performance last week with the S&P 500 and the Dow Jones adding 0.7% and 0.9%, respectively and the Nasdaq Composite losing 0.1% last week. However, the Dow Jones...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Tapestry...

The second-quarter earnings season has effectively come to an end for most of the sectors, except retail, nearly 34% of which is still to report. Total earnings for the companies that have reported so...

Catalent (NYSE:CTLT), Inc. CTLT has been gaining on the back of its slew of strategic deals over the past few months. A robust third-quarter fiscal 2021 performance, along with integrated development...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different...

Investors have dual reasons to be upbeat about the Moderna (NASDAQ:MRNA) MRNA stock. To begin with, the FDA has finally given a nod to the COVID-19 vaccine booster shots of Pfizer PFE-BioNTech or...

Genome editing is a technique to alter or modify the DNA of a cell or organism. It uses an enzyme to cut the DNA at a particular sequence and then is repaired by the cell, making a change to the...

If it weren’t for all the new highs, you could call this a boring week for the market. Two of the major indices grinded higher and set fresh records throughout the period, yet their weekly...

If it weren’t for all the new highs, you could call this a boring week for the market. Two of the major indices grinded higher and set fresh records throughout the period, yet their weekly...

If it weren’t for all the new highs, you could call this a boring week for the market. Two of the major indices grinded higher and set fresh records throughout the period, yet their weekly...